About
Karen S. Anderson is a Professor of Pharmacology and Molecular Biophysics and Biochemistry at Yale School of Medicine, with a primary appointment in the Department of Pharmacology. She serves as Co-Leader of Developmental Therapeutics at Yale Cancer Center and Co-Director of the Therapeutics/Chemotherapy Program. Dr. Anderson is also an undergraduate research mentor and fellow at Pierson College at Yale, where she advises freshman students.
Dr. Anderson's research program focuses on mechanistic enzymology and structure-based drug design to develop novel therapeutics. Her work centers on understanding molecular mechanisms of enzymes that play critical roles in cancer and infectious diseases, including HIV/AIDS. She has made significant contributions to the understanding of HIV reverse transcriptase, anticancer targets like EGFR and HER-2, and enzymes involved in parasitic infections. Her laboratory employs a multidisciplinary approach combining biophysical techniques, structural studies, and computational methods to advance drug discovery.
Analysis of her recent publications (2023-2025) reveals a strong research trajectory spanning three main areas: HIV drug resistance and novel inhibitors, cancer therapeutics focusing on resistance mechanisms and targeted therapies, and antiviral/antimicrobial drug development including work on SARS-CoV-2. Her research demonstrates consistent innovation in structure-based drug design approaches across multiple disease areas.
Selected Awards and Honors:
- Enzymes, Coenzymes, & Metabolic Pathways Gordon Research Conference Chair (2001)
- Yale Cancer Breast Cancer Initiative Research Award (1996)
- Dean's Young Faculty Award from Yale University (1991)
- Multiple Monsanto Research Achievement Awards (1985-1989)
- YWCA Women's Leadership Award (1986-1987)
Dr. Anderson has trained over 50 undergraduates, graduate students, M.D./Ph.D. students and postdoctoral fellows who have gone on to successful careers in academia and industry. Her laboratory, the Anderson Lab, focuses on translating mechanistic and structural studies into novel therapeutic approaches for viral infections and cancer. The lab utilizes a range of biophysical techniques to study clinically relevant proteins with the goal of developing more effective therapies for conditions including cancer, infectious diseases, and neurodegenerative disorders.
